Optimising the Upstream Drug Substance Process to Increase Yield, Enhance Purity, and Streamline Scalability in mRNA Manufacturing
Time: 11:30 am
day: Day Two
Details:
- How to intensify the upstream process to maximize mRNA yield while maintaining efficiency and consistency.
- How to optimize reaction conditions to minimize impurities like dsRNA and improve overall mRNA purity.
- How to scale up IVT reactions to ensure seamless tech transfer from clinical to commercial production.
